DUOS vs Moderna
Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $130M strategic growth equity led by FTV Capital in October 2025, bringing total funding to $163M to expand its senior-focused AI platform across Medicare Advantage, Medicaid, and ACA markets.
About
DUOS is an AI-powered digital health platform purpose-built for senior member activation and benefits execution, helping health plans drive engagement and measurable outcomes across their populations. The platform connects older adults to untapped benefits, care resources, and social services through a personalized AI layer integrated with payer workflows. Backed by $163M in total funding including FTV Capital and Forerunner Ventures, DUOS is scaling rapidly across Medicare Advantage and Medicaid nationally.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
About
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.